The BioMind AI system was developed by the Artificial Intelligence Research Centre for Neurological Disorders at the Beijing Tiantan Hospital and it has scored 2:0 against elite physicians in a brain diagnosing competition held in Beijing. The AI made correct diagnoses in 87% of 225 cases in roughly 15 minutes, whereas the team of human doctors only managed to achieve a 66% accuracy. BioMind was also successful in detecting brain hematoma expansion cases. In order for BioMind to be trained, the developers fed it thousands of images of nervous system diseases that were archived by the hospital in the past 10 years. Its success was not intended to pit the doctors against medical technology, on the contrary, it would be expected for the AI to work with the medical professionals and make those who were skeptical about it more accepting.

An AI has defeated China's top doctors when competing on detection of a brain tumors and predicting the hematoma expansion. The system defeated a team of doctors who were top 15 in the nation. The AI is named BioMind and it was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Tiantan Hospital in Beijing. BioMind was correct 87% of the time while the doctors have reached 66% accuracy. While the AI took just 15 minutes to find 225 cases the doctors took double the time.

An AI system has wiped the floor with some of China's top doctors when it comes to diagnosing brain tumors and predicting hematoma expansion. As reported by Xinhua, the system defeated a team comprised of 15 of China's top doctors by a margin of two to one. The AI, BioMind, was developed by the Artificial Intelligence Research Centre for Neurological Disorders at Beijing Tiantan Hospital, and is another example of the long line of the technology analyzing images. When diagnosing brain tumors, BioMind was correct 87 percent of the time, compared to 66 percent by the medical professionals. The AI also only took 15 minutes to diagnose the 225 cases, while doctors took 30.